That was my initial thought.
If it was a double-blinded trial, of course.
How can they say 90% effective if half the trial received placebo?
Anyway, I haven’t read it: it was a media release, perfectly timed to just after the election, and wasn’t peer-reviewed.
Im sceptical, given all the data about short-lived antibodies...
Pfizer, page-21
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
22.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $86.90M | |||
| Open | High | Low | Value | Volume |
| 22.5¢ | 22.5¢ | 21.0¢ | $91.02K | 417.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2325 | 21.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 22.0¢ | 119713 | 2 |
View Market Depth
| Last trade - 16.10pm 06/05/2024 (20 minute delay) ? |
|
|||||
|
Last
22.0¢ |
Change
0.000 ( 5.72 %) |
||||
| Open | High | Low | Volume | ||
| 23.0¢ | 23.0¢ | 21.0¢ | 271600 | ||
| Last updated 15.42pm 06/05/2024 ? | |||||
| PAA (ASX) Chart |